We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01424319
First Posted: August 29, 2011
Last Update Posted: August 29, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )